Cargando…

Patients with Hypocortisolism Treated with Continuous Subcutaneous Hydrocortisone Infusion (CSHI): An Option for Poorly Controlled Patients

OBJECTIVE: Despite appropriate oral glucocorticoid replacement therapy, patients with hypocortisolism often suffer from impaired health and frequent hospitalizations. Continuous subcutaneous hydrocortisone infusion (CSHI) has been developed as an attempt to improve the health status of these patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mortensen, Malene Lyder, Ornstrup, Marie Juul, Gravholt, Claus H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042637/ https://www.ncbi.nlm.nih.gov/pubmed/36994228 http://dx.doi.org/10.1155/2023/5315059

Ejemplares similares

Management of adrenocortical insufficiency with continuous subcutaneous hydrocortisone infusion: long-term experience in three patients
por: Khanna, A, et al.
Publicado: (2015)

Hypocortisolism in survivors of SARS
por: Lofthouse, Marie
Publicado: (2005)

Results of the Prolonged Use of Subcutaneous Continuous Infusion of Hydrocortisone in a Man with Congenital Adrenal Hyperplasia
por: Sonnet, Emmanuel, et al.
Publicado: (2011)

RF09 | PSAT84 Management of Adrenal Insufficiency with Continuous Subcutaneous Hydrocortisone Infusion: Long-Term Experience in 27 Patients
por: Lalani, Atul, et al.
Publicado: (2022)

Modelling Hydrocortisone Pharmacokinetics on a Subcutaneous Pulsatile Infusion Replacement Strategy in Patients with Adrenocortical Insufficiency
por: Violaris, Ioannis G., et al.
Publicado: (2021)

Presence, patterns & predictors of hypocortisolism in patients with HIV infection in India
por: Sharma, Neera, et al.
Publicado: (2018)

Delayed Onset of Central Hypocortisolism in a Patient Recovering From COVID-19
por: Chua, Marvin Wei Jie, et al.
Publicado: (2020)

HYPOCORTISOLISM IN A PATIENT WITH COVID-19: A CASE REPORT AND DISCUSSION ON MANAGEMENT
por: AYAT, PARINAZ, et al.
Publicado: (2021)

A case of congestive heart failure caused by secondary hypocortisolism
por: Nagura, Fukuko, et al.
Publicado: (2017)

Defining Nonfunctioning Adrenal Adenomas on the Basis of the Occurrence of Hypocortisolism after Adrenalectomy
por: Eller-Vainicher, Cristina, et al.
Publicado: (2020)

Bolus or continuous hydrocortisone – that is the question
por: Weber-Carstens, Steffen, et al.
Publicado: (2007)

Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012)

What to do now that hypocortisol appears to be a predominant sign of long COVID?
por: Kirschbaum, Clemens
Publicado: (2022)

Hydrocortisone infusion may improve survival in patients with severe community-acquired pneumonia
por: Raghavan, Murugan, et al.
Publicado: (2005)

A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
por: Pozzilli, Paolo, et al.
Publicado: (2015)

Comparison of Hydrocortisone Continuous Rate Infusion and Prednisolone or Dexamethasone Administration for Treatment of Acute Hypoadrenocortical (Addisonian) Crisis in Dogs
por: Mitropoulou, Athanasia, et al.
Publicado: (2022)

Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses vs Continuous Infusion in Septic Shock: A Retrospective Study
por: Mitwally, Hassan, et al.
Publicado: (2021)

Cost-Effectiveness of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Patients with Poorly Controlled Type 2 Diabetes in Finland
por: Roze, Stephané, et al.
Publicado: (2019)

Duration of post-operative hypocortisolism predicts sustained remission after pituitary surgery for Cushing’s disease
por: Bansal, Prachi, et al.
Publicado: (2017)

Psychopathology and Continuous Subcutaneous Insulin Infusion in Type 1 Diabetes
por: Rotella, Francesco, et al.
Publicado: (2013)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Hyperglycemia Risk Evaluation of Hydrocortisone Intermittent Boluses versus Continuous Infusion in Septic Shock: A Prospective Randomized Trial
por: Ram, Ganesh Kumar, et al.
Publicado: (2022)

Use of continuous subcutaneous anesthetic infusion in cardiac surgical patients after median sternotomy
por: Koukis, Ioannis, et al.
Publicado: (2008)

Burnout and Hypocortisolism – A Matter of Severity? A Study on ACTH and Cortisol Responses to Acute Psychosocial Stress
por: Lennartsson, Anna-Karin, et al.
Publicado: (2015)

Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
por: Ziegler, Ralph, et al.
Publicado: (2021)

Successful treatment of adult‐onset nesidioblastosis by continuous subcutaneous octreotide infusion in a patient on hemodialysis
por: Kato, Rina, et al.
Publicado: (2020)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
por: Baker, J., et al.
Publicado: (2020)

Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic control
por: van Hooijdonk, Roosmarijn T. M., et al.
Publicado: (2015)

Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes
por: Li, Feng-fei, et al.
Publicado: (2018)

Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
por: Lyu, Fu-ping, et al.
Publicado: (2020)

Continuous subcutaneous apomorphine infusion allowing awake deep brain stimulation in a Parkinson’s disease patient
por: Spagnolo, Francesca, et al.
Publicado: (2021)

Continuous Subcutaneous Insulin Infusion Therapy Resulting in Improved Glycemic Control in Patient With Low Health Literacy
por: Mandal, Shobha, et al.
Publicado: (2021)

Continuous subcutaneous insulin infusion is associated with a reduced rate of microvascular complications
por: Zabeen, Bedowra, et al.
Publicado: (2015)

Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population
por: Armstrong, Peter, et al.
Publicado: (2018)

Continuous subcutaneous insulin infusion and flash glucose monitoring in diabetic hemiballism-hemichorea
por: Qiang, Wei, et al.
Publicado: (2020)

Continuous Subcutaneous Apomorphine Infusion in Advanced Parkinson’s Disease: A Systematic Review
por: Gaire, Suman, et al.
Publicado: (2021)

Impact of Hydrocortisone and of CRH Infusion on the Hypothalamus-Pituitary-Adrenocortical Axis of Septic Male Mice
por: Téblick, Arno, et al.
Publicado: (2021)

Transsphenoidal pituitary adenoma resection: do early post-operative cortisol levels predict permanent long-term hypocortisolism?
por: Butenschoen, Vicki M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_opbhh3rs7e80vjpvrh0nlr5r80